Cardiac Fibrosis and Curcumin: A Novel Perspective on This Natural Medicine Publisher Pubmed



Sadoughi F¹ ; Hallajzadeh J² ; Mirsafaei L³ ; Asemi Z¹ ; Zahedi M⁴ ; Mansournia MA⁵ ; Yousefi B^{6, 7} Show Affiliations
Source: Molecular Biology Reports Published:2021

Abstract

Background: According to WHO statistics, cardiovascular disease are the leading causes of death in the world. One of the main factors which is causing heart failure, systolic and diastolic dysfunction, and arrythmias is a condition named cardiac fibrosis. This condition is defined by the accumulation of fibroblast-produced ECM in myocardium layer of the heart. Objective: Accordingly, the current review aims to depict the role of curcumin in the regulation of different signaling pathways that are involved in cardiac fibrosis. Results: A great number of cellular and molecular mechanisms such as oxidative stress, inflammation, and mechanical stress are acknowledged to be involved in cardiac fibrosis. Despite the available therapeutic procedures which are designed to target these mechanisms in order to prevent cardiac fibrosis, still, effective therapeutic methods are needed. Curcumin is a natural Chinese medicine which currently has been declared to have therapeutic properties such as anti-oxidant and immunomodulatory activities. In this review, we have gathered several experimental studies in order to represent diverse impacts of this turmeric derivative on pathogenic factors of cardiac fibrosis. Conclusion: Curcumin might open new avenues in the field of cardiovascular treatment. © 2021, The Author(s), under exclusive licence to Springer Nature B.V.